Hepatic deletion of LRH-1 leads to imbalanced arachidonic acid-phospholipid metabolism due to repression of Elovl5 and Fads2 and increased hepatic steatosis and liver injury [513], while activation of LRH-1 improves fatty liver [514]. Here, NR5A2 is linked to fatty liver disease.